MAGIC: Multi-scale Heterogeneity Analysis and Clustering for Brain
  Diseases
  There is a growing amount of clinical, anatomical and functional evidence for
the heterogeneous presentation of neuropsychiatric and neurodegenerative
diseases such as schizophrenia and Alzheimers Disease (AD). Elucidating
distinct subtypes of diseases allows a better understanding of
neuropathogenesis and enables the possibility of developing targeted treatment
programs. Recent semi-supervised clustering techniques have provided a
data-driven way to understand disease heterogeneity. However, existing methods
do not take into account that subtypes of the disease might present themselves
at different spatial scales across the brain. Here, we introduce a novel
method, MAGIC, to uncover disease heterogeneity by leveraging multi-scale
clustering. We first extract multi-scale patterns of structural covariance
(PSCs) followed by a semi-supervised clustering with double cyclic block-wise
optimization across different scales of PSCs. We validate MAGIC using simulated
heterogeneous neuroanatomical data and demonstrate its clinical potential by
exploring the heterogeneity of AD using T1 MRI scans of 228 cognitively normal
(CN) and 191 patients. Our results indicate two main subtypes of AD with
distinct atrophy patterns that consist of both fine-scale atrophy in the
hippocampus as well as large-scale atrophy in cortical regions. The evidence
for the heterogeneity is further corroborated by the clinical evaluation of two
subtypes, which indicates that there is a subpopulation of AD patients that
tend to be younger and decline faster in cognitive performance relative to the
other subpopulation, which tends to be older and maintains a relatively steady
decline in cognitive abilities.
